The correct analysis using the data given in the review article is as follows. The incidence of intravascular placement of an epidural catheter is 0.01 to 4 per cent. Using the midpoint figure, the probability of intravascular placement in any one patient is two per cent, in the absence of an)' information from test doses.
In a random group of 100 patients, then, only two will have intravascular placement. Since the sensitivity of the test is 50 per cent (given in the article), one of the two will test positive. On the other hand, of the 98 patients with correct epidural placement, 12 will have a positive test (because of the false positive rate).
This means that in lOCI patients, 13 will have a positive response to testing for intravascular placement. However, in only one of these thirteen will the positive test actually predict a real catheter misplacement, i.e., the positive predictive value of this test is 1/13, or only 7.7 per cent.
In contrast, 12 of 13 patients, or 92.3 per cent, will have had their catheters removed unnecessarily. This figure, which is much higher than that of Dain et al., imp]ies that the routine use of a test dose for intravascular injection is even less useful than they suggest.
Note that this conclusion is for the use of a test dose as a means of detecting intravascular injection. For test doses to detect subarachnoid injections, the predictive value can be shown to be much higher, and therefore to be more useful.
The above analysis suggests several interesting points regarding the use of a clinical test as an indicator or predictor of the occurrence of an event. Firstly, the sensitivity or specificity of the test is commonly confused with its positive predictive value. Sensitivity can be defined as the probability of obtaining a positive test result if the event under test is already known to have occurred; similarly, specificity is the probability of getting a negative test if the event is known to have not occurred. Since the occurrence or non-occurrence of an event is not known in clinical settings, sensitivity and specificity are not parameters with direct interpretations at the bedside. On the other hand, the positive predictive value is the probability of the occurrence of the event /f the test is positive; this is obviously of more immediate clinical relevance. The three parameters are related, as the previous calculations showed, or more elegantly by use of Bayes' theorem.
Secondly, unlikely occurrences remain unlikely even in the face of a positive test, unless the test has a specificity close to 100 per cent. In the ease of epidural test doses, the pre-test probability of intravascular injection, two per cent, increases only to 7.7 per cent after a positive test response.
More generally, the predictive value of a test is related by Bayes' theorem to the pro-test probability of the event. This implies that the usefulness of a clinical test rests partially on the patient population for which it is used. For example, since the incidence of accidental intravascular injection can be expected to be higher if there was a preceding "bloody tap," test doses may be useful in this circumstance, as suggested by Biehl. 
